Coronavirus News and Research

RSS

Latest SARS outbreak contained, but biosafety concerns remain

It has been more than three weeks since the last case was placed in isolation in China's latest SARS outbreak, prompting the World Health Organization to declare that the chain of human-to- human transmission appears to have been broken.

18 May 2004

Study has found the Sars virus in sweat glands and the intestine

Pathologists from the First Military Medical University in Guangzhou, southern China, warn that if further research proves that Sars can be transmitted by these unexpected routes, the implications for public health are major.

7 May 2004

Investigation to find the source of the current SARS outbreak

Investigation of the source of the current outbreak, first reported on 22 April, continues to focus on the National Institute of Virology in Beijing. The institute is known to have conducted experiments using the live SARS coronavirus during February and March.

5 May 2004

China, SARS ourbreak contained

Chinese authorities have today reported test results confirming that the 53-year-old woman who died in Anhui Province on 19 April was infected with the SARS coronavirus. The woman, a medical doctor, was the mother of a 26-year-old postgraduate student who had been conducting research at the National Institute of Virology in Beijing. The student remains hospitalized in Anhui.

30 Apr 2004

Chinese authorities announce 9th suspected SARS case

Chinese health authorities have announced that an additional case of SARS is under investigation. This brings the total number of cases in China, reported since 22 April, to nine. Of these, one has died.

29 Apr 2004

SARS experts head to China

At the request of the Chinese Ministry of Health, WHO is today sending the first members of an international team to help investigate the source of SARS cases recently reported in Beijing and the eastern province of Anhui. The team, which is expected to begin work on Wednesday, will include experts in epidemiology, virology, infection control, and laboratory biosafety.

26 Apr 2004

SARS antibody sent to China

Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.

26 Apr 2004

Severe Acute Respiratory Syndrome (SARS) overview

Severe Acute Respiratory Syndrome (SARS) is an atypical form of pneumonia that first appeared in November 2002 in Guangdong Province, China.

24 Apr 2004

4th reported SARS case in China

The Chinese Ministry of Health has today reported an additional three cases of SARS, including one death. This brings the current number of persons with a clinical illness compatible with SARS in China to four.

24 Apr 2004

First Chinese case of case of SARS since January 2004

On April 22, 2004, the Chinese Ministry of Health reported a possible case of severe acute respiratory syndrome (SARS) in a 20-year-old woman who works as a nurse in a hospital in Beijing. If confirmed, this will be the first case of SARS since January 2004, when Chinese health authorities confirmed SARS coronavirus (SARS-CoV) infection in three persons in Guangdong Province.

23 Apr 2004

Possible new SARS case in Beijing, China

22 Apr 2004

An experimental vaccine based on a critical piece of the SARS virus

An experimental vaccine based on a critical piece of the SARS virus protects mice from SARS infection, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have found.

19 Apr 2004

SARS virus vaccine stimulates protective immune response

An experimental vaccine prevents the SARS virus from replicating in laboratory mice, according to a new report in the April 1 issue of Nature. Scientists at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, developed the vaccine. The vaccine was tested in a mouse model of SARS infection recently validated by other NIAID investigators.

31 Mar 2004